Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report) saw an uptick in trading volume on Wednesday . 4,010 shares changed hands during mid-day trading, an increase of 125% from the previous session’s volume of 1,781 shares.The stock last traded at $0.61 and had previously closed at $0.6439.
Sino Biopharmaceutical Stock Performance
The company has a 50 day moving average price of $0.62 and a 200-day moving average price of $0.73.
About Sino Biopharmaceutical
Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.
The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.
Featured Stories
- Five stocks we like better than Sino Biopharmaceutical
- Buy the Dip or Run: 3 Software Stocks Down 50% Face Their Moment of Truth
- IonQ Sparks a Quantum Grid Revolution
- No Hangover: Revisiting Microsoft One Week After Earnings
- Western Digital Stock Falls 12% Despite Beating Earnings Estimates
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
